Skip to main content

Among the challenges are moments of joy.

The federal government is committed to making every day better for people with dementia, their caregivers, and their families.

 

Find out how we’re taking action.

Why Participate in a Clinical Trial?

When you volunteer for a clinical trial, you help bring us closer to Alzheimer’s treatment and prevention discoveries.

News & Events

Scientists looking at a computer screen, studying how blood markers may track FTD.
Blood marker shows potential for tracking frontotemporal dementia
An NIA-supported study finds blood marker shows potential for tracking frontotemporal dementia.
3D Graphic showing blood vessels in the brain.
Two molecular maps of blood vessels in the human brain reveal links to dementia
Two studies extensively analyze blood vessels in the human brain on a single-cell level and show that changes in the molecular makeup of these vessels are linked to dementia.
Dr. Richard J. Hodes
NIA statement on CMS Medicare coverage policy for approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s
Read the NIA Director's statement on CMS Medicare coverage policy for approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s